Related Experiment Video

Updated: Sep 20, 2026

Individualized Reconstitution of Human Milk Microbiota: A Feasible Approach in Real-World Settings
04:16

Individualized Reconstitution of Human Milk Microbiota: A Feasible Approach in Real-World Settings

Published on: February 7, 2025

Infant formulas. Recent developments and new issues

C Agostoni1, F Haschke

  • 1Department of Pediatrics, San Paolo Hospital, University of Milan, Milan, Italy.

Minerva Pediatrica
|August 6, 2003
PubMed

Insights

Modern infant formulas aim to replicate the functional outcomes of breast milk, incorporating ingredients like LCPUFA, probiotics, prebiotics, and nucleotides to support infant development and health. Further long-term studies are needed to confirm benefits for neural performance and obesity prevention.

Area of Science:

  • Pediatrics
  • Nutrition Science
  • Immunology

Background:

  • Infant formulas serve as a crucial alternative to breast milk for infants whose mothers cannot breastfeed.
  • Current formulas aim to mimic the functional outcomes of breastfed infants, not the exact composition of human milk.

Purpose of the Study:

  • To review key compounds added to infant formulas: long-chain polyunsaturated fatty acids (LCPUFA), probiotics, prebiotics, and nucleotides.
  • To assess the impact of protein quantity, quality, and hydrolyzed proteins on infant development and health.
  • To highlight the need for long-term follow-up data on infants fed updated formulas.

Main Methods:

  • Review of scientific literature on added compounds in infant formulas.
  • Analysis of studies examining protein modifications and their effects.
  • Identification of research gaps concerning long-term infant outcomes.

Main Results:

  • LCPUFA, probiotics, prebiotics, and nucleotides are incorporated to support brain development, gut health, and immune response.
  • Adjustments in protein content and quality may influence amino acid balance and potentially prevent later overweight.
  • Hydrolyzed proteins show promise in preventing atopic disorders.
  • Existing short-term studies generally report positive findings.

Conclusions:

  • Current infant formulas are enhanced with specific nutrients to support infant development and health.
  • While short-term results are promising, long-term data is essential to fully understand the impact on neural development, obesity, and immune-allergic patterns.
  • Further research focusing on long-term follow-up is crucial for optimizing infant formula development.

More Related Videos

Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers09:36

Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers

Published on: July 28, 2022

Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation09:02

Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation

Published on: February 15, 2018

Related Concept Videos

Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
FDA Approved Drugs: Changes to Approved Drugs01:26

FDA Approved Drugs: Changes to Approved Drugs

Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
Biopharmaceutical Factors Influencing Drug Product Design: Overview01:22

Biopharmaceutical Factors Influencing Drug Product Design: Overview

Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...